EXPLORE-OSA Drug Candidate Trial Fully Enrolled
Mineralys Therapeutics’ lorundrostat targets nocturnal hypertension linked to sleep apnea.
Read More
Author: Sleep Review Staff
HST Coding Updates: Earn Continuing Education
Earn sleep continuing education credits (CSTEs) from Sleep Review’s May 2025 digital edition.
Read More
First US Commercial Patients Implanted with Genio System
Physicians show ‘strong demand’ for the neurostimulator for obstructive sleep apnea patients, says Nyxoah CEO.
Read More
AI Sleep Phone Earns NIH Grant
The National Institute on Aging is funding SleepSpace to study whether its AI-driven smartphone platform can deliver digital CBT-I while reducing phone-related sleep disruption in older adults.
Read More
How AI Could Up CPAP Adherence: Earn Continuing Education
Earn sleep continuing education credits (CSTEs) from Sleep Review’s April 2025 digital edition.
Read More